keyword
https://read.qxmd.com/read/37846293/post-biphosphonate-mandible-osteonecrosis-a-case-study-and-literature-review
#1
JOURNAL ARTICLE
Bambara H Aboubacar, Zerbo Nina Assanatou Jumelle, Valerie Odero-Marah, Ki Thierry Romuald, Oué Draogo Y C Laetitia, Konsem Tarcissus
PURPOSE: Bisphosphonates have proven effective in reducing pain and skeletal events in bone metastases treatment. However, there is a long-term complication called osteonecrosis of the jaw, which has been reported for more than a decade. Despite various professional recommendations, there is no international consensus on the best therapeutic strategy. Prevention is crucial, and a multidisciplinary approach must be tailored to each stage of the condition. DESIGN: We present a case of osteonecrosis of the jaw in a patient with metastatic breast cancer who was receiving 4 mg injectable zoledronic acid...
September 2023: Oral Oncol Rep
https://read.qxmd.com/read/35573963/safety-and-efficacy-of-pamidronate-in-neonatal-hypercalcemia-caused-by-subcutaneous-fat-necrosis-a-case-report
#2
Stefano Martinelli, Marco Pitea, Italo Francesco Gatelli, Tara Raouf, Graziano Barera, Ottavio Vitelli
Subcutaneous fat necrosis of the newborn (SCFN) is a panniculitis that develops in fatty areas after fetal or perinatal distress. Prognosis is generally good with complete regression, but it can be complicated by metabolic abnormalities like hypoglycemia, hypertriglyceridemia, thrombocytopenia, and also potentially life-threatening hypercalcemia. Treatments have included hydration, furosemide and corticosteroids. These treatments can be prolonged for several days and can have complications such as nephrocalcinosis...
2022: Frontiers in Pediatrics
https://read.qxmd.com/read/34745472/calcitonin-fortical-miacalcin-for-the-treatment-of-vertebral-compression-fractures
#3
JOURNAL ARTICLE
Alicia Kaneb, Kevin Berardino, Josephine S Hanukaai, Kelsey Rooney, Alan D Kaye
Purpose of Review: Osteoporosis is a common condition affecting the musculoskeletal system. It carries with it increased risks of fracture in many areas of the body, leading to reduced quality of life, limited mobility, and other long-term implications such as chronic pain. Vertebral compression fractures are a common development in patients with osteoporosis. Current treatment options focus on reducing pain; preventative methods are somewhat limited and focus on minimizing risk factors for the development of osteoporosis...
2021: Orthopedic Reviews
https://read.qxmd.com/read/33299563/management-of-cancer-pain-with-analgetic-adjuvant-and-weak-opioid-in-prostate-cancer-bone-metastases-a-case-series
#4
JOURNAL ARTICLE
Jufriady Ismy, Dessy Rakhmawati Emril, Rizkidawati
BACKGROUND: In cancer patients, cancer pain is the most common cancer complication. About 60-90% of patients with advanced stage cancer experience various levels of pain, and about 30% of patients have been suffering from persistent severe pain. Bones are the most frequent targets of metastases in patients with cancer such as breast, prostate, lung, kidney, and thyroid. In advanced prostate cancer, bone metastasis leads to bone pain, skeletal fracture, and increased mortality. At least 75% of patients with bone metastasis experience bone pain...
December 2020: Annals of Medicine and Surgery
https://read.qxmd.com/read/33143100/use-of-cad-cam-bridging-mandibular-prosthesis-in-osteonecrosis-of-the-jaw-the-experience-of-our-school
#5
JOURNAL ARTICLE
Francesco Ricotta, Salvatore Battaglia, Federico Bolognesi, Francesco Ceccariglia, Claudio Marchetti, Achille Tarsitano
Osteonecrosis of the jaw (ONJ) is a disease that affects the jaw. It is mainly related to radiation or bisphosphonates therapy, and the symptoms and signs consist of pain, bone exposure, inflammation of the surrounding soft tissue swelling, and secondary infection or drainage. In the case of advanced disease of the mandibular area, the treatment of choice is mandibular resection and reconstruction. In the present study, we report a case series of patients affected by ONJ and treated with a customised bridging mandibular prosthesis-only technique...
October 30, 2020: Journal of Clinical Medicine
https://read.qxmd.com/read/30217487/myoglobinuria-in-two-patients-with-duchenne-muscular-dystrophy-after-treatment-with-zoledronate-a-case-report-and-call-for-caution
#6
JOURNAL ARTICLE
Anton Ivanyuk, Nuria García Segarra, Thierry Buclin, Andrea Klein, David Jacquier, Christopher J Newman, Clemens Bloetzer
Rhabdomyolysis with myoglobinuria is a recognized complication of dystrophinopathies. It can be triggered by infections, exercise or volatile anesthetics. To our knowledge, it has never been reported in boys with Duchenne muscular dystrophy (DMD) after the administration of bisphosphonates. We report two patients with DMD who presented an apparent transient rhabdomyolysis with myoglobinuria after zoledronate administration. Possible mechanisms could involve hypophosphatemia, a known dose-dependent side effect of bisphosphonates, and/or direct myotoxicity of biphosphonates...
October 2018: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/29709532/-severe-hypercalcemia-of-unusual-cause-looking-for-the-culprit-case-report-and-review-of-the-literature
#7
REVIEW
M Jalbert, A Mignot, A-S Gauchez, A-C Dobrokhotov, J Fourcade
INTRODUCTION: Hypercalcemia is not a rare event and can lead to severe consequences. Its main etiologies are primary hyperparathyroidism and neoplasic conditions. The iatrogenic etiology by vitamin D intoxication is more rarely found. CASE PRESENTATION: A 76-year-old finish woman comes to the emergency room for chest pain. Her medical history is impossible to specify due to the language barrier and initial confusion. She has severe hypercalcaemia (4.14mmol/L), renal insufficiency, cardiac arrhythmia later complicated by an ischemic cardiac episode...
June 2018: Néphrologie & Thérapeutique
https://read.qxmd.com/read/28030966/systemic-drugs-that-influence-titanium-implant-osseointegration
#8
REVIEW
Dragos Apostu, Ondine Lucaciu, Gheorghe Dan Osvald Lucaciu, Bogdan Crisan, Liana Crisan, Mihaela Baciut, Florin Onisor, Grigore Baciut, Radu Septimiu Câmpian, Simion Bran
Titanium implants are widely used on an increasing number of patients in orthopedic and dental medicine. Despite the good survival rates of these implants, failures that lead to important socio-economic consequences still exist. Recently, research aimed at improving implant fixation, a process called osseointegration, has focused on a new, innovative field: systemic delivery of drugs. Following implant fixation, patients receive systemic drugs that could either impair or enhance osseointegration; these drugs include anabolic and anti-catabolic bone-acting agents in addition to new treatments...
February 2017: Drug Metabolism Reviews
https://read.qxmd.com/read/26587372/osteonecrosis-of-the-jaw-during-biyearly-treatment-with-zoledronic-acid-for-aromatase-inhibitor-associated-bone-loss-in-early-breast-cancer-a-literature-review
#9
REVIEW
Hampig Raphael Kourie, Joelle Antoun, Elie El Rassy, Marc Rassy, Claude Sader-Ghorra, Joseph Kattan
Osteonecrosis of the jaw (ONJ) is one of the most relevant and specific complication of biphosphonates. ONJ in patients receiving zoledronic acid every 3 to 4 weeks is frequently described, but the ONJ biyearly regimen used to reduce aromatase inhibitor associated bone loss (AIBL), is rarely reported. A literature review, focusing on the important trials using zoledronic acid to reduce AIBL, found that the mean risk of developing ONJ when zoledronic acid is used biyearly varies between 0.12% and 0.7%.
September 2015: Journal of Bone Oncology
https://read.qxmd.com/read/25823488/treatment-considerations-in-hutchinson-gilford-progeria-syndrome-a-case-report
#10
JOURNAL ARTICLE
H Hazan-Molina, D Aizenbud, Aizenbud D Dror
Hutchinson-Guilford progeria syndrome is an extremely rare condition classified as one of the premature ageing syndromes. This case presents a 16-year-old Israeli female patient, suffering from a variant of Hutchinson-Guilford progeria with a history of treatment with oral biphosphnates. The patient presented with typical cranial and facial features of the syndrome including delayed teeth eruption and root development probably due to insufficient jaw growth and severs retrognatic position of the maxilla and mandible...
2015: Journal of Clinical Pediatric Dentistry
https://read.qxmd.com/read/25674321/oral-bisphosphonate-associated-osteonecrosis-of-maxillary-bone-a-review-of-18-cases
#11
JOURNAL ARTICLE
Edgardo López-D'alessandro, Fabiana Mardenlli, Marisa Paz
Biphosphonate-associated maxillary bone osteonecrosis (BPMO) is a complication related to nitrogen-containing biphosphonate therapy. This adverse effect occasionally appears in patients who are administered biphosphonates through intravenous infusion for the treatment of cancer involving bone metastases. It can also present, in a lesser degree, in patients who take these drugs orally for the treatment of osteoporosis. Lately, there has been an increase in the number of cases of osteopenia and osteoporosis due to the increasing life expectancy of the world's population...
December 2014: Journal of Clinical and Experimental Dentistry
https://read.qxmd.com/read/24640211/sickle-cell-disease-with-osteogenesis-imperfecta
#12
JOURNAL ARTICLE
P L Patil, B Varun Rao
A 16 yr old female presented with generalized weakness and easy fatigability since 2 months. Her medical history included that she had sickle cell disease (ss pattern) on regular treatment. She denied smoking and consumption of alcohol. She had adequate calcium intake and her menstrual history was non-contributory. History of right tibial diaphysial fracture 1 year back followed by refracture at the same site 6 months later. On examination patient was 146 cm tall & weighed 48 kg. She had pallor, blue-grey sclera,scar mark of previous operation on right leg...
June 2013: Journal of the Association of Physicians of India
https://read.qxmd.com/read/24403442/the-key-role-of-bisphosphonates-in-the-supportive-care-of-cancer-patients
#13
REVIEW
Maria Tolia, Anna Zygogianni, John R Kouvaris, Christos Meristoudis, Niki Margari, Petros Karakitsos, Ioannis Kokakis, Dimitrios Kardamakis, Christos Papadimitriou, Kyriaki Mystakidou, Nikolaos Tsoukalas, George Kyrgias, Basil Armonis, Dimitrios K Filippiadis, Alexios D Kelekis, Nikolaos Kelekis, Vasileios Kouloulias
UNLABELLED: The present review aims at providing an assessment of the clinical significance of Biphosphonates (BPs) in the treatment of patients with cancer. MATERIALS AND METHODS: A systematic literature review was performed based on database search in PubMed/Medline and included articles up to August 2013. RESULTS: BPs can reduce, delay, and prevent complications related to bone metastases. They improve mobility, functionality, pain, and quality of life...
January 2014: Anticancer Research
https://read.qxmd.com/read/24180669/radiometabolic-treatment-of-bone-metastasizing-cancer-from-186rhenium-to-223radium
#14
REVIEW
Giuseppe Rubini, Adriano Nicoletti, Domenico Rubini, Artor Niccoli Asabella
Skeletal metastases occur in many patients with different kinds of malignant tumors, especially in advance stage of breast cancer (in 47%-85% of patients), prostate cancer (33-85%), and lung cancer (32%-60%). The management of painful skeletal metastases is complicated and should be carried out by a multidisciplinary approach including conventional analgesics, antitumor therapy (chemo- and hormone therapy), osteoclast-inhibitory agents (bisphosphonates), corticosteroids, external-beam radiotherapy, surgery, and nuclear medicine therapy...
February 2014: Cancer Biotherapy & Radiopharmaceuticals
https://read.qxmd.com/read/23697351/-osteogenesis-imperfecta-experience-of-dona-estef%C3%A3-nia-s-hospital-orthopedics-department
#15
JOURNAL ARTICLE
Carlos Escobar, Duarte Malveiro, António Salgado, Maria Inês Santos, João Lameirão Campagnolo, Manuel Cassiano Neves
INTRODUCTION/AIMS: Osteogenesis imperfecta (OI) is a genetic disorder characterized by bone fragility and osteopenia. Treatment involves a multidisciplinary approach and aims to improve the quality of life. The authors aimed to describe the characteristics of a sample of children with OI, to evaluate the treatment and clinical outcome before and after therapy. MATERIAL AND METHODS: An observational, longitudinal, retrospective and analytic study based on data obtained from the analisys of the clinical files of all patients with OI included in the pamidronate treatment protocol in Dona Estefânia's Hospital...
January 2013: Acta Médica Portuguesa
https://read.qxmd.com/read/23681089/pseudoarthrosis-in-atypical-femoral-fracture-case-report
#16
JOURNAL ARTICLE
S Giannotti, V Bottai, G Dell'Osso, G De Paola, M Ghilardi, G Guido
Atypical femoral fractures can be subsequent to a long-term biphosphonates treatment; they have a high frequency of delayed healing. The authors describe a femoral pseudoarthrosis of an atypical fracture treated with intramedullary nailing in a female after prolonged alendronate therapy. Atypical femoral fractures can be subsequent to a long-term biphosphonates treatment even if, in the literature, there is no clarity on the exact pathogenetic mechanism. The Task Force of the American Society for Bone and Mineral Research described the major and minor features to define atypical fractures and recommends that all the five major features must be present while minor features are not necessary...
November 2013: Osteoporosis International
https://read.qxmd.com/read/23608208/-what-do-we-know-about-atypical-fractures-in-patients-on-biphosphonates-treatment-a-literature-review-using-a-case-series
#17
REVIEW
A Méndez-Gil, S Prat-Fabregat, A Domingo-Trepat, M Navarro-López, P Camacho-Carrasco, A Carreño-Delgado, J A Zumbado-Dijeres, R García-Elvira, M Ríos-Martín, R García-Tarriño, O Ares-Rodríguez, J R Ballesteros-Betancourt, S Suso-Vergara
AIM: Retrospective review of long term biphosphonates treated patients who sustained a subtrochanteric or diaphyseal femoral fracture with an atypical pattern. A literature review is presented as an update of the topic. MATERIAL AND METHODS: A retrospective study was conducted on 13 subtrochanteric or diaphyseal fractures in female patients treated with biphosphonates at our institution from September 2007 to March 2011. RESULTS: Four cases of subtrochanteric fractures and 13 diaphyseal fractures were detected...
March 2013: Revista Española de Cirugía Ortopédica y Traumatología
https://read.qxmd.com/read/23301428/-zoledronic-acid-based-uveitis-a-case-report-and-a-bibliography-review
#18
REVIEW
Mario Albani-Campanario, Gerardo Buendía-Díaz, María de Lourdes Flores-Islas, Carlos Maquita-Nakano, Josefina Ochoa-Cervantes
There are several treatment options for postmenopausic patients suffering from ostopenia or osteoporosis; one of them being inhibition of bone resorption using bisphosphonates. The most common side effects of these drugs are of gastrointestinal nature. There are, of course, other side effects that could jeopardize the function and integrity of other organs or systems. A case of a 58-year-old patient presenting zoledronic-acid induced uveitis symptoms is reported. The importance of this paper lies in that this complication is rather exceptional, in particular if associated with the biphosphonate in question...
May 2012: Ginecología y Obstetricia de México
https://read.qxmd.com/read/22626807/type-1-interferons-suppress-accelerated-osteoclastogenesis-and-prevent-loss-of-bone-mass-during-systemic-inflammatory-responses-to-pneumocystis-lung-infection
#19
JOURNAL ARTICLE
Michelle Wilkison, Katherine Gauss, Yanchao Ran, Steve Searles, David Taylor, Nicole Meissner
HIV infection causes loss of CD4(+) T cells and type 1 interferon (IFN)-producing and IFN-responsive dendritic cells, resulting in immunodeficiencies and susceptibility to opportunistic infections, such as Pneumocystis. Osteoporosis and bone marrow failure are additional unexplained complications in HIV-positive patients and patients with AIDS, respectively. We recently demonstrated that mice that lack lymphocytes and IFN a/b receptor (IFrag(-/-)) develop bone marrow failure after Pneumocystis lung infection, whereas lymphocyte-deficient, IFN α/β receptor-competent mice (RAG(-/-)) had normal hematopoiesis...
July 2012: American Journal of Pathology
https://read.qxmd.com/read/21926848/bone-within-bone-appearance-a-red-flag-for-biphosphonate-associated-osteonecrosis-of-the-jaw
#20
JOURNAL ARTICLE
Girish M Fatterpekar, Julius Valentin Emmrich, Jean Anderson Eloy, Amit Aggarwal
OBJECTIVE: Osteonecrosis of the jaws is recognized as a serious complication of biphosphonate therapy. The purpose of this study was to characterize the computed tomography (CT) imaging appearance of biphosphonate-associated osteonecrosis and to evaluate for distinguishing features of radiation-induced osteonecrosis (RION), osteomyelitis (OM), and metastases. METHODS: We retrospectively reviewed CT scans of 6 patients with biopsy-proven biphosphonate-associated osteonecrosis (BAON)...
September 2011: Journal of Computer Assisted Tomography
keyword
keyword
116660
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.